Dengue fever: the urgent hunt for antivirals and vaccines
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers overcome obstacles to…
By
There are 100–400 million Dengue fever infections each year, and cases are quickly rising. How can manufacturers overcome obstacles to…
ByFive more study centres in Brazil as well as a third Canadian site in Toronto, Ontario will become operational soon.
Set to be carried out in Panama, the trial is anticipated to enrol up to 240 healthy subjects.
The trial will assess the safety and efficacy of up to three intravenous doses of COVI-MSC administered on alternate days.
The trial to assess the efficacy and safety of apabetalone will enrol 100 subjects at centres in Canada and Brazil.
The trial will enrol 90 subjects to assess the safety, tolerability, and immunogenicity of three dose levels of the vaccine.
The trial plans to enrol approximately 1,600 Covid-19 patients, with recruitment progressing at 12 trial centres in Brazil.
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next…
By